Literature DB >> 992473

Presentation of therapeutic results in carcinoma of the female pelvis: experience of the Annual Report on the Results of Treatment in Carcinoma of the Uterus, Vagina, and Ovary.

H L Kottmeier.   

Abstract

Entities:  

Mesh:

Year:  1976        PMID: 992473     DOI: 10.1016/0090-8258(76)90002-0

Source DB:  PubMed          Journal:  Gynecol Oncol        ISSN: 0090-8258            Impact factor:   5.482


× No keyword cloud information.
  5 in total

1.  The management of hydronephrosis in patients undergoing TURBT.

Authors:  N Thiruchelvam; G Ubhayakar; H Mostafid
Journal:  Int Urol Nephrol       Date:  2006       Impact factor: 2.370

2.  [Treatment of vulvar cancer (author's transl)].

Authors:  M Volk; H Schmidt-Matthiesen
Journal:  Arch Gynakol       Date:  1977-09-30

3.  Human carcinoma cell lines xenografted in athymic mice: biological and antigenic characteristics of an intraabdominal model.

Authors:  M Ripamonti; S Canevari; S Ménard; D Mezzanzanica; S Miotti; R Orlandi; F Rilke; E Tagliabue; M I Colnaghi
Journal:  Cancer Immunol Immunother       Date:  1987       Impact factor: 6.968

4.  CA 125 half-life in ovarian cancer: a multivariate survival analysis.

Authors:  C A Yedema; P Kenemans; F Voorhorst; G Bon; C Schijf; L Beex; A Verstraeten; J Hilgers; J Vermorken
Journal:  Br J Cancer       Date:  1993-06       Impact factor: 7.640

5.  Reduced expression of BAX is associated with poor prognosis in patients with epithelial ovarian cancer: a multifactorial analysis of TP53, p21, BAX and BCL-2.

Authors:  M Schuyer; M E van der Burg; S C Henzen-Logmans; J H Fieret; J G Klijn; M P Look; J A Foekens; G Stoter; E M Berns
Journal:  Br J Cancer       Date:  2001-11-02       Impact factor: 7.640

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.